Brief: Onxeo announces chief medical and scientific officers

Valerio Therapeutics SA

01/03/2017 17:01

March 1 (Reuters) - Onxeo SA  C4X.PA : 
    * Francoise Bono, PHD, named chief scientific officer to 
lead preclinical activities 
    * Olivier de beaumont, MD, MBA, appointed chief medical 
officer to lead clinical development and operations, medical and 
regulatory affairs 
 
Source text for Eikon:  ID:nBw3h3vHKa  
Further company coverage:  C4X.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))